Concepedia

Matthew Correa

MC

Statistics

Publications

8

Citations

666

H-Index

8

Active since

2015

Affiliations

Bristol-Myers Squibb (United States)(Current)

Matthew Correa is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

2015–2023

8

Publications

8

Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma

Joshua D. Hansen, Matthew Correa, Mark A. Nagy et al. · Journal of Medicinal Chemistry · 2020 · 218 citations · Full text

Medicine, Oncology, Pharmacology +13

CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia

Joshua D. Hansen, Matthew Correa, Matt Alexander et al. · Journal of Medicinal Chemistry · 2021 · 149 citations · Full text

Medicine, Medicinal Chemistry, Oncology +13

Protein Degradation via CRL4<sup>CRBN</sup> Ubiquitin Ligase: Discovery and Structure–Activity Relationships of Novel Glutarimide Analogs That Promote Degradation of Aiolos and/or GSPT1

Joshua D. Hansen, Kevin R. Condroski, Matthew Correa et al. · Journal of Medicinal Chemistry · 2017 · 76 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115

Deborah S. Mortensen, Sophie Perrin-Ninkovic, Graziella Shevlin et al. · Journal of Medicinal Chemistry · 2015 · 73 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Vulnerability and risk: climate change and water supply from California’s Central Valley water system

Patrick Ray, Sungwook Wi, Andrew Schwarz et al. · Climatic Change · 2020 · 57 citations

Natural Resources, Hydrology, Water Resources Management +14

1–5 of 8